{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:48:53Z","timestamp":1786121333358,"version":"build-2736575974"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.neuropharm.2026.111126","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T15:13:07Z","timestamp":1785337987000},"page":"111126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Involvement of the cannabinoid receptors of the basolateral amygdala in the orexin A-mediated modulation of the stress-induced analgesia"],"prefix":"10.1016","volume":"299","author":[{"given":"Mahnaz","family":"Aghaei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roghaieh","family":"Khakpay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Khakpai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadali Hosseinpour","family":"Feizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2026.111126_bib1","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0306-4522(99)00445-5","article-title":"Role of gonadal hormones in formalin-induced pain responses of male rats: modulation by estradiol and naloxone administration","volume":"95","author":"Aloisi","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2026.111126_bib2","first-page":"205","article-title":"The role of hypocretin\/orexin in stress-induced analgesia","volume":"22","author":"Azhdari-Zarmehri","year":"2015","journal-title":"J. Kerman Univ. Med. Sci."},{"key":"10.1016\/j.neuropharm.2026.111126_bib3","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.pbb.2014.03.017","article-title":"Orexin-A microinjection into the rostral ventromedial medulla causes antinociception on formalin test","volume":"122","author":"Azhdari-Zarmehri","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2026.111126_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ph12020099","article-title":"Psychotropic drugs for the management of chronic pain and itch","volume":"12","author":"Belinskaia","year":"2019","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.neuropharm.2026.111126_bib5","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.neuropharm.2012.10.024","article-title":"Serotonergic neural links from the dorsal raphe nucleus modulate defensive behaviours organised by the dorsomedial hypothalamus and the elaboration of fear-induced antinociception via locus coeruleus pathways","volume":"67","author":"Biagioni","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111126_bib6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0304-3959(00)00470-X","article-title":"Orexin-A, an hypothalamic peptide with analgesic properties","volume":"92","author":"Bingham","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2026.111126_bib7","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/jnr.23975","article-title":"Orexin-A increases the firing activity of hippocampal CA1 neurons through orexin-1 receptors","volume":"95","author":"Chen","year":"2017","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2026.111126_bib8","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.2174\/138161210793292483","article-title":"Orexins\/hypocretins: pain regulation and cellular actions","volume":"16","author":"Chiou","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.neuropharm.2026.111126_bib9","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/npp.2015.173","article-title":"Orexin-A and endocannabinoid activation of the descending antinociceptive pathway underlies altered pain perception in Leptin signaling deficiency","volume":"41","author":"Cristino","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2026.111126_bib10","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0006-3223(01)01328-2","article-title":"Anxiety and affective style: role of prefrontal cortex and amygdala","volume":"51","author":"Davidson","year":"2002","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.111126_bib11","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1017\/S1461145713000163","volume":"16","author":"de Freitas","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2026.111126_bib12","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1007\/s00213-022-06199-1","article-title":"An interaction between basolateral amygdala orexinergic and endocannabinoid systems in inducing anti-nociception in the rat formalin test","volume":"239","author":"Deli","year":"2022","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2026.111126_bib13","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.1523\/JNEUROSCI.0372-06.2006","article-title":"Cannabinoid receptor type 1 located on presynaptic terminals of principal neurons in the forebrain controls glutamatergic synaptic transmission","volume":"26","author":"Domenici","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111126_bib14","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.npep.2017.07.006","article-title":"Involvement of GABAA receptors in the regulation of social preference and emotional behaviors by oxytocin in the central amygdala of female mandarin voles","volume":"66","author":"Dong","year":"2017","journal-title":"Neuropeptides"},{"key":"10.1016\/j.neuropharm.2026.111126_bib15","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.neuroscience.2008.12.008","article-title":"Acid-sensitive TASK-like K+ conductances contribute to resting membrane potential and to orexin-induced membrane depolarization in rat thalamic paraventricular nucleus neurons","volume":"158","author":"Doroshenko","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2026.111126_bib16","doi-asserted-by":"crossref","first-page":"934","DOI":"10.3389\/fnins.2018.00934","article-title":"Orexin depolarizes central amygdala neurons via orexin receptor 1, phospholipase C and sodium-calcium exchanger and modulates conditioned fear","volume":"12","author":"Dustrude","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111126_bib17","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1002\/ejp.899","article-title":"Functional interaction between orexin-1 and CB1 receptors in the periaqueductal gray matter during antinociception induced by chemical stimulation of the lateral hypothalamus in rats","volume":"20","author":"Esmaeili","year":"2016","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.neuropharm.2026.111126_bib18","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1111\/bph.13440","article-title":"Involvement of the orexin\/hypocretin system in the pharmacological effects induced by \u0394(9) -tetrahydrocannabinol","volume":"173","author":"Flores","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111126_bib19","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.brainres.2009.09.096","article-title":"GABAA receptor blockade in dorsomedial and ventromedial nuclei of the hypothalamus evokes panic-like elaborated defensive behaviour followed by innate fear-induced antinociception","volume":"1305","author":"Freitas","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2026.111126_bib20","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.biopsych.2014.09.008","article-title":"The central amygdala as an integrative hub for anxiety and alcohol use disorders","volume":"77","author":"Gilpin","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.111126_bib22","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1111\/j.1460-9568.2007.05476.x","article-title":"Correlated species differences in the effects of cannabinoid ligands on anxiety and on GABAergic and glutamatergic synaptic transmission","volume":"25","author":"Haller","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111126_bib21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/YCO.0b013e32834de34f","article-title":"Current animal models of anxiety, anxiety disorders, and anxiolytic drugs","volume":"21","author":"Haller","year":"2012","journal-title":"Curr. Opin. Psychiatr."},{"key":"10.1016\/j.neuropharm.2026.111126_bib23","doi-asserted-by":"crossref","first-page":"14600","DOI":"10.1523\/JNEUROSCI.2671-11.2011","article-title":"Activation of orexin 1 receptors in the periaqueductal gray of male rats leads to antinociception via retrograde endocannabinoid (2-arachidonoylglycerol)-induced disinhibition","volume":"31","author":"Ho","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111126_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2014.06.003","article-title":"Stress-induced hyperalgesia","volume":"121","author":"Jennings","year":"2014","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2026.111126_bib24","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.bbrc.2014.02.026","article-title":"Human orexin\/hypocretin receptors form constitutive homo- and heteromeric complexes with each other and with human CB1 cannabinoid receptors","volume":"445","author":"J\u00e4ntti","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2026.111126_bib26","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0006-8993(82)91055-1","article-title":"Amygdalar vocalization pathways in the squirrel monkey","volume":"241","author":"J\u00fcrgens","year":"1982","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2026.111126_bib27","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.neuint.2016.08.007","article-title":"Chronic stress and moderate physical exercise prompt widespread common activation and limited differential activation in specific brain regions","volume":"99","author":"Kim","year":"2016","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2026.111126_bib28","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.neuroscience.2008.06.059","article-title":"Orexin peptides enhance median preoptic nucleus neuronal excitability via postsynaptic membrane depolarization and enhancement of glutamatergic afferents","volume":"155","author":"Kolaj","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2026.111126_bib29","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.neuropharm.2016.02.018","article-title":"Stress induces analgesia via orexin 1 receptor-initiated endocannabinoid\/CB1 signaling in the mouse periaqueductal gray","volume":"105","author":"Lee","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111126_bib30","doi-asserted-by":"crossref","first-page":"700","DOI":"10.2522\/ptj.20100330","article-title":"Impact of psychological factors in the experience of pain","volume":"91","author":"Linton","year":"2011","journal-title":"Phys. Ther."},{"key":"10.1016\/j.neuropharm.2026.111126_bib31","doi-asserted-by":"crossref","first-page":"229","DOI":"10.31887\/DCNS.2020.22.3\/rmaldonado","article-title":"The endocannabinoid system in modulating fear, anxiety, and stress","volume":"22","author":"Maldonado","year":"2020","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111126_bib32","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nature00839","article-title":"The endogenous cannabinoid system controls extinction of aversive memories","volume":"418","author":"Marsicano","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2026.111126_bib33","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1177\/1073858403261077","article-title":"The amygdala and persistent pain","volume":"10","author":"Neugebauer","year":"2004","journal-title":"Neuroscientist"},{"key":"10.1016\/j.neuropharm.2026.111126_bib34","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00213-024-06701-x","article-title":"Orexin mechanisms in the prelimbic cortex modulate the expression of contextual conditioned fear","volume":"242","author":"Oliveira","year":"2025","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2026.111126_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-53012-9","article-title":"Orexin A as a modulator of dorsal lateral geniculate neuronal activity: a comprehensive electrophysiological study on adult rats","volume":"9","author":"Orlowska-Feuer","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2026.111126_bib36","series-title":"The Rat Brain in Stereotaxic coordinates-the New Coronal Set","author":"Paxinos","year":"2004"},{"key":"10.1016\/j.neuropharm.2026.111126_bib37","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2007"},{"key":"10.1016\/j.neuropharm.2026.111126_bib38","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.neuroscience.2011.08.037","article-title":"Endocannabinoid signaling in the amygdala: anatomy, synaptic signaling, behavior, and adaptations to stress","volume":"204","author":"Ramikie","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2026.111126_bib39","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.biopha.2017.03.053","article-title":"A review of the role of orexin system in pain modulation","volume":"90","author":"Razavi","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.neuropharm.2026.111126_bib40","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.pain.2012.12.021","article-title":"Evidence for a role of GABAergic and glutamatergic signalling in the basolateral amygdala in endocannabinoid-mediated fear-conditioned analgesia in rats","volume":"154","author":"Rea","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2026.111126_bib41","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1111\/j.1460-9568.2007.05861.x","article-title":"The effect of CB1 receptor antagonism in the right basolateral amygdala on conditioned fear and associated analgesia in rats","volume":"26","author":"Roche","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111126_bib42","doi-asserted-by":"crossref","first-page":"20260","DOI":"10.1073\/pnas.1320325110","article-title":"Orexin\/hypocretin system modulates amygdala-dependent threat learning through the locus coeruleus","volume":"110","author":"Sears","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2026.111126_bib43","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.1523\/JNEUROSCI.4718-10.2011","article-title":"Cannabinoid transmission in the basolateral amygdala modulates fear memory formation via functional inputs to the prelimbic cortex","volume":"31","author":"Tan","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111126_bib44","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/8296501","article-title":"Amygdala plasticity and pain","volume":"2017","author":"Thompson","year":"2017","journal-title":"Pain Res. Manag."},{"key":"10.1016\/j.neuropharm.2026.111126_bib45","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.npep.2016.12.007","article-title":"The analgesic effect of orexin-A in a murine model of chemotherapy-induced neuropathic pain","volume":"61","author":"Toyama","year":"2016","journal-title":"Neuropeptides"},{"key":"10.1016\/j.neuropharm.2026.111126_bib46","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1124\/mol.112.078063","article-title":"OX1 orexin\/hypocretin receptor signaling through arachidonic acid and endocannabinoid release","volume":"82","author":"Turunen","year":"2012","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111126_bib47","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2049-9256-1-9","article-title":"The amygdala between sensation and affect: a role in pain","volume":"1","author":"Veinante","year":"2013","journal-title":"J. Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.111126_bib48","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.pain.2005.12.014","article-title":"Mesolimbic dopaminergic mechanisms and pain control","volume":"120","author":"Wood","year":"2006","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2026.111126_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109168","article-title":"Contextual generalization of social stress learning is modulated by orexin receptors in basolateral amygdala","volume":"215","author":"Yaeger","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111126_bib50","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0304-3940(03)00716-X","article-title":"Anti-mechanical allodynic effect of intrathecal and intracerebroventricular injection of orexin-A in the rat neuropathic pain model","volume":"347","author":"Yamamoto","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2026.111126_bib51","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.pain.2010.08.016","article-title":"Brain correlates of stress-induced analgesia","volume":"151","author":"Yilmaz","year":"2010","journal-title":"PAIN\u00ae"},{"key":"10.1016\/j.neuropharm.2026.111126_bib52","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0165-0173(02)00248-5","article-title":"The human amygdala and the emotional evaluation of sensory stimuli","volume":"41","author":"Zald","year":"2003","journal-title":"Brain Res. Rev."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826003011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826003011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T04:25:35Z","timestamp":1786076735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826003011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":52,"alternative-id":["S0028390826003011"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111126","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Involvement of the cannabinoid receptors of the basolateral amygdala in the orexin A-mediated modulation of the stress-induced analgesia","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111126","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111126"}}